{
    "raw_data": {
        "nct_id": "NCT00061308",
        "official_title": "An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer",
        "criteria": {
            "raw_text": "Inclusion Criteria:\n\n* Have had one prior platinum-based chemotherapy regimen for the treatment of primary disease.\n* At least 4 weeks since last surgery or radiation therapy.\n* Must have had a treatment-free interval of greater than 6 months following response to platinum.\n* ECOG performance status of 0,1, or 2.\n\nExclusion Criteria:\n\n* Women of child-bearing potential that do not practice adequate contraception.\n* Pregnant or lactating.\n* Received more than one primary chemotherapy regimen.\n* Concomitant or previous malignancies with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer from which the patient has been disease free for 5 years.\n* Active uncontrolled infection requiring antibiotics.\n* Concurrent severe medical problems unrelated to the malignancy which would limit full compliance with the study.\n* Received radiation to more than 10% of bone.\n* Prior treatment with topotecan or gemcitabine.\n* Hypersensitivity to camptothecin or nucleoside analogues.\n* Use of an investigational agent within 30 days."
        }
    },
    "structurized": {
        "raw_text": "Inclusion Criteria:\n\n* Have had one prior platinum-based chemotherapy regimen for the treatment of primary disease.\n* At least 4 weeks since last surgery or radiation therapy.\n* Must have had a treatment-free interval of greater than 6 months following response to platinum.\n* ECOG performance status of 0,1, or 2.\n\nExclusion Criteria:\n\n* Women of child-bearing potential that do not practice adequate contraception.\n* Pregnant or lactating.\n* Received more than one primary chemotherapy regimen.\n* Concomitant or previous malignancies with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer from which the patient has been disease free for 5 years.\n* Active uncontrolled infection requiring antibiotics.\n* Concurrent severe medical problems unrelated to the malignancy which would limit full compliance with the study.\n* Received radiation to more than 10% of bone.\n* Prior treatment with topotecan or gemcitabine.\n* Hypersensitivity to camptothecin or nucleoside analogues.\n* Use of an investigational agent within 30 days.",
        "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
        "category_reasoning": "The criterion is a compound criterion because it consists of multiple individual criteria that can be separated into distinct questions for inclusion and exclusion.",
        "overall_thoughts": "The criterion is well-structured, listing clear inclusion and exclusion criteria for the clinical trial. Each point can be addressed individually to determine eligibility.",
        "logical_operator": "AND",
        "criterions": [
            {
                "raw_text": "Have had one prior platinum-based chemotherapy regimen for the treatment of primary disease.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion specifies a single condition that can be answered with a yes or no: whether the patient has had one prior platinum-based chemotherapy regimen for the treatment of primary disease.",
                "overall_thoughts": "This criterion is straightforward, specifying a treatment history requirement for eligibility.",
                "root_term": "chemotherapy regimen",
                "qualifiers": [
                    "one prior",
                    "platinum-based",
                    "for the treatment of primary disease"
                ],
                "relation_type": "have had",
                "target": [
                    {
                        "answer": "yes",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "This criterion is likely used to ensure that participants have a specific treatment history, which may be relevant for the study's focus on treatment-experienced individuals."
                ]
            },
            {
                "raw_text": "At least 4 weeks since last surgery or radiation therapy.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion specifies a single condition regarding the time elapsed since the last surgery or radiation therapy, which can be answered with a simple yes or no.",
                "overall_thoughts": "This criterion is straightforward, specifying a minimum time period that must have passed since the patient's last surgery or radiation therapy.",
                "root_term": "time since last surgery or radiation therapy",
                "qualifiers": [
                    "at least 4 weeks"
                ],
                "relation_type": "temporal",
                "target": [
                    {
                        "answer": "4 weeks or more",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "This criterion is likely intended to ensure sufficient recovery time post-surgery or radiation therapy before participating in the trial."
                ]
            },
            {
                "raw_text": "Must have had a treatment-free interval of greater than 6 months following response to platinum.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion specifies a single condition that can be evaluated with a straightforward question regarding the patient's treatment history and response to platinum.",
                "overall_thoughts": "This criterion is clear and specifies a condition related to the patient's treatment history with platinum-based therapies. It requires a specific treatment-free interval following a response to platinum, which is a common consideration in oncology trials.",
                "root_term": "treatment-free interval",
                "qualifiers": [
                    "greater than 6 months",
                    "following response to platinum"
                ],
                "relation_type": "must have had",
                "target": [
                    {
                        "answer": "Yes",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "This criterion is relevant for patients who have previously been treated with platinum-based therapies and have had a response, indicating a period of remission or stability."
                ]
            },
            {
                "raw_text": "ECOG performance status of 0,1, or 2.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion specifies a single condition related to the ECOG performance status, which can be answered with a simple yes or no question regarding the patient's status.",
                "overall_thoughts": "This criterion is straightforward, specifying acceptable ECOG performance statuses for trial eligibility.",
                "root_term": "ECOG performance status",
                "qualifiers": [],
                "relation_type": "equals",
                "target": [
                    {
                        "answer": "0",
                        "dependent_criterion": null
                    },
                    {
                        "answer": "1",
                        "dependent_criterion": null
                    },
                    {
                        "answer": "2",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "ECOG performance status is a scale used to assess how a patient's disease is progressing, including their level of functioning and ability to care for themselves."
                ]
            },
            {
                "raw_text": "Women of child-bearing potential that do not practice adequate contraception.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion is straightforward and can be answered with a simple yes or no question regarding the practice of adequate contraception among women of child-bearing potential.",
                "overall_thoughts": "This criterion is focused on ensuring that women who are capable of becoming pregnant are using effective birth control methods, likely to prevent any potential risks to a fetus during the trial.",
                "root_term": "Women of child-bearing potential",
                "qualifiers": [
                    "that do not practice adequate contraception"
                ],
                "relation_type": "exclusion",
                "target": [
                    {
                        "answer": "do not practice adequate contraception",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "This criterion is likely in place to prevent pregnancy during the trial, which could pose risks to both the participant and a potential fetus."
                ]
            },
            {
                "raw_text": "Pregnant or lactating.",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion involves two separate conditions: being pregnant and being lactating. Each condition can be considered independently, making it a compound criterion.",
                "overall_thoughts": "This criterion is straightforward as it involves two distinct conditions that are often considered separately in clinical trials.",
                "root_term": "Pregnant",
                "qualifiers": [],
                "relation_type": "or",
                "target": [
                    {
                        "answer": "Yes",
                        "dependent_criterion": null
                    },
                    {
                        "answer": "Lactating",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "Pregnancy and lactation are often exclusion criteria in clinical trials due to potential risks to the fetus or infant."
                ]
            },
            {
                "raw_text": "Received more than one primary chemotherapy regimen.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no, based on whether the patient has received more than one primary chemotherapy regimen.",
                "overall_thoughts": "This criterion is clear and specific, focusing on the number of primary chemotherapy regimens a patient has received.",
                "root_term": "primary chemotherapy regimen",
                "qualifiers": [
                    "more than one"
                ],
                "relation_type": "received",
                "target": [
                    {
                        "answer": "yes",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": []
            },
            {
                "raw_text": "Concomitant or previous malignancies with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer from which the patient has been disease free for 5 years.",
                "category": "hierarchical_criterion- when there is a parent criterion and a child criterion which adds further criteria should the parent be true.",
                "category_reasoning": "The criterion specifies a general condition (concomitant or previous malignancies) and then provides exceptions to this condition (adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer from which the patient has been disease free for 5 years). This structure indicates a hierarchical relationship where the exceptions are dependent on the initial condition being true.",
                "overall_thoughts": "This criterion is structured to exclude patients with certain malignancies unless they fall into specific exception categories. The exceptions are clearly defined, making it a hierarchical criterion.",
                "parent_criterion": {
                    "raw_text": "Concomitant or previous malignancies",
                    "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                    "category_reasoning": "The criterion is a straightforward statement about the presence of concomitant or previous malignancies, which can be answered with a yes or no.",
                    "overall_thoughts": "This criterion is checking for the presence of any other malignancies, either currently or in the past, which could affect the trial's outcomes or the patient's eligibility.",
                    "root_term": "malignancies",
                    "qualifiers": [
                        "concomitant",
                        "previous"
                    ],
                    "relation_type": "presence",
                    "target": [
                        {
                            "answer": "yes",
                            "dependent_criterion": null
                        }
                    ],
                    "additional_information": []
                },
                "child_criterion": {
                    "raw_text": "with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer from which the patient has been disease free for 5 years.",
                    "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                    "category_reasoning": "The criterion lists multiple exceptions to a general exclusion of cancer, each of which can be considered a separate criterion. These exceptions are joined by the logical operator 'OR'.",
                    "overall_thoughts": "This criterion specifies exceptions to a general exclusion of patients with a history of cancer. It allows patients with certain types of cancer or those who have been disease-free for a specified period to be eligible. The use of 'or' indicates that meeting any one of these conditions is sufficient for eligibility.",
                    "logical_operator": "OR",
                    "criterions": [
                        {
                            "raw_text": "adequately treated basal cell skin cancer",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is straightforward and can be answered with a simple yes or no question regarding the patient's medical history.",
                            "overall_thoughts": "This criterion is checking for a specific medical condition and its treatment status, which is common in clinical trial eligibility criteria to ensure patient safety and relevance to the study.",
                            "root_term": "basal cell skin cancer",
                            "qualifiers": [
                                "adequately treated"
                            ],
                            "relation_type": "status",
                            "target": [
                                {
                                    "answer": "yes",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": [
                                "Basal cell skin cancer is a common form of skin cancer that is often treated successfully. The criterion specifies that the cancer must have been adequately treated, implying that the patient is currently not suffering from active disease."
                            ]
                        },
                        {
                            "raw_text": "adequately treated squamous cell skin cancer",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is straightforward and can be answered with a simple yes or no question regarding the patient's medical history.",
                            "overall_thoughts": "This criterion is checking for a specific medical history condition, namely whether the patient has had squamous cell skin cancer that has been adequately treated.",
                            "root_term": "squamous cell skin cancer",
                            "qualifiers": [
                                "adequately treated"
                            ],
                            "relation_type": "condition",
                            "target": [
                                {
                                    "answer": "yes",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": [
                                "This criterion is likely used to ensure that patients with a history of squamous cell skin cancer are eligible if their condition has been resolved adequately."
                            ]
                        },
                        {
                            "raw_text": "in situ cervical cancer",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is a straightforward medical condition that can be answered with a yes or no regarding the patient's medical history.",
                            "overall_thoughts": "This criterion is simple and focuses on whether the patient has a specific medical condition, in situ cervical cancer.",
                            "root_term": "cervical cancer",
                            "qualifiers": [
                                "in situ"
                            ],
                            "relation_type": "has",
                            "target": [
                                {
                                    "answer": "yes",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": [
                                "In situ cervical cancer refers to a non-invasive form of cervical cancer where the cancerous cells are confined to the surface layer of the cervix."
                            ]
                        },
                        {
                            "raw_text": "incidental carcinoid",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is a simple statement that can be answered with a yes or no regarding the presence of an incidental carcinoid.",
                            "overall_thoughts": "This criterion is straightforward, focusing on the presence of an incidental carcinoid, which is a type of tumor that is often found unexpectedly.",
                            "root_term": "carcinoid",
                            "qualifiers": [
                                "incidental"
                            ],
                            "relation_type": "presence",
                            "target": [
                                {
                                    "answer": "present",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": [
                                "Carcinoids are a type of neuroendocrine tumor that can occur in several places throughout the body."
                            ]
                        },
                        {
                            "raw_text": "other cancer from which the patient has been disease free for 5 years",
                            "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                            "category_reasoning": "The criterion is a single condition that can be evaluated with a straightforward question about the patient's medical history regarding other cancers and their disease-free status for a specified duration.",
                            "overall_thoughts": "This criterion is straightforward, focusing on the patient's history with other cancers and their disease-free status for a period of 5 years. It is a common eligibility criterion to ensure that participants do not have a recent history of other cancers that could confound the study results.",
                            "root_term": "other cancer",
                            "qualifiers": [
                                "from which the patient has been disease free for 5 years"
                            ],
                            "relation_type": "disease-free duration",
                            "target": [
                                {
                                    "answer": "5 years disease-free",
                                    "dependent_criterion": null
                                }
                            ],
                            "additional_information": [
                                "This criterion is likely used to exclude patients with a recent history of other cancers to avoid confounding factors in the trial."
                            ]
                        }
                    ]
                },
                "additional_information": [
                    "The criterion is designed to exclude patients with a history of malignancies unless they meet specific exception criteria, indicating a focus on ensuring patient safety and trial integrity."
                ]
            },
            {
                "raw_text": "Active uncontrolled infection requiring antibiotics.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion is a single condition that can be evaluated with a yes or no answer, specifically whether the participant has an active uncontrolled infection requiring antibiotics.",
                "overall_thoughts": "This criterion is straightforward, focusing on the presence of an active infection that is not controlled and necessitates antibiotic treatment.",
                "root_term": "infection",
                "qualifiers": [
                    "active",
                    "uncontrolled",
                    "requiring antibiotics"
                ],
                "relation_type": "requires",
                "target": [
                    {
                        "answer": "yes",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "The criterion implies that participants with such infections are likely excluded from the trial due to potential complications or interactions with the study treatment."
                ]
            },
            {
                "raw_text": "Concurrent severe medical problems unrelated to the malignancy which would limit full compliance with the study.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion is a single statement that can be addressed with a yes or no answer regarding the presence of severe medical problems unrelated to the malignancy.",
                "overall_thoughts": "This criterion excludes participants who have other severe medical issues that could interfere with their ability to fully comply with the study requirements, ensuring that the study results are not confounded by unrelated health issues.",
                "root_term": "medical problems",
                "qualifiers": [
                    "concurrent",
                    "severe",
                    "unrelated to the malignancy"
                ],
                "relation_type": "limit",
                "target": [
                    {
                        "answer": "full compliance with the study",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "This criterion ensures that participants can adhere to the study protocol without interference from other health issues."
                ]
            },
            {
                "raw_text": "Received radiation to more than 10% of bone.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion is a straightforward statement that can be answered with a yes or no, based on whether the patient has received radiation to more than 10% of their bone.",
                "overall_thoughts": "This criterion is clear and specific, focusing on the extent of radiation received by the bone, which is a quantifiable measure.",
                "root_term": "radiation",
                "qualifiers": [
                    "received",
                    "to more than 10% of bone"
                ],
                "relation_type": "received",
                "target": [
                    {
                        "answer": "yes",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "The criterion implies a history of treatment involving radiation, specifically targeting the bone."
                ]
            },
            {
                "raw_text": "Prior treatment with topotecan or gemcitabine.",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion involves two separate drugs, topotecan and gemcitabine, either of which could have been used in prior treatment. This makes it a compound criterion as it can be split into two distinct questions regarding prior treatment with each drug.",
                "overall_thoughts": "The criterion specifies that the patient must have had prior treatment with either topotecan or gemcitabine. This is a straightforward inclusion or exclusion criterion based on treatment history.",
                "root_term": "treatment",
                "qualifiers": [
                    "prior"
                ],
                "relation_type": "with",
                "target": [
                    {
                        "answer": "topotecan",
                        "dependent_criterion": null
                    },
                    {
                        "answer": "gemcitabine",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "The criterion is likely used to exclude patients who have already been treated with these drugs, possibly to test the efficacy of a new treatment or to avoid confounding effects."
                ]
            },
            {
                "raw_text": "Hypersensitivity to camptothecin or nucleoside analogues.",
                "category": "compound_Criterion- when there are two or more criterions which can be seperated into various questions",
                "category_reasoning": "The criterion involves hypersensitivity to either camptothecin or nucleoside analogues, which can be considered as two separate conditions to evaluate.",
                "overall_thoughts": "The criterion specifies two different substances to which a participant may have hypersensitivity. Each substance represents a separate condition to check for eligibility.",
                "root_term": "Hypersensitivity",
                "qualifiers": [],
                "relation_type": "to",
                "target": [
                    {
                        "answer": "camptothecin",
                        "dependent_criterion": null
                    },
                    {
                        "answer": "nucleoside analogues",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": []
            },
            {
                "raw_text": "Use of an investigational agent within 30 days.",
                "category": "atomic_Criterion- where there is only one criterion that can be answered with a simple question",
                "category_reasoning": "The criterion is a straightforward exclusion based on the use of an investigational agent within a specified timeframe, which can be answered with a simple yes or no.",
                "overall_thoughts": "This criterion is designed to exclude participants who have recently used investigational agents, likely to avoid confounding effects or interactions with the trial treatment.",
                "root_term": "Use of an investigational agent",
                "qualifiers": [
                    "within 30 days"
                ],
                "relation_type": "temporal",
                "target": [
                    {
                        "answer": "Yes",
                        "dependent_criterion": null
                    }
                ],
                "additional_information": [
                    "Investigational agents are typically drugs or therapies that are not yet approved for general use and are being studied in clinical trials."
                ]
            }
        ]
    }
}